[Hilarix Corporation] 2026 Midterm Financial Results | Sales of ¥209.1 billion (37.3% increase)

Performance Overview

Hilarix Corporation recorded net sales of ¥209.1 billion (up 37.3% YoY) and net income of ¥34.8 billion (up 823.8% YoY) for the second quarter of the 2026 fiscal year. The effects of acquiring the new consolidated subsidiary Hilarix Act significantly contributed to the growth in both sales and profits. Extraordinary gains included an impairment loss of negative goodwill of ¥28.3 billion and gains from sale of investment securities amounting to ¥8.3 billion, which contributed to a substantial increase in ordinary income. The financial position also improved with total assets increasing to ¥366.3 billion; although the equity ratio decreased to 58.0%, net assets rose to ¥232.8 billion.

Future Outlook and Impact on Shareholders

The company will continue to promote business expansion and technological innovation utilizing newly consolidated subsidiaries, strengthening its global presence. Dividend payments are expected to increase from ¥53.50 per share at the end of the second quarter to an annual forecast of ¥80.00 per share. As part of its capital policy and business strategy, the company will actively pursue investments and M&A to enhance corporate value. Investors can expect a promising outlook with strengthened growth foundations and increased dividends.